<DOC>
	<DOC>NCT00077987</DOC>
	<brief_summary>Assessment of safety and efficacy of SU11248 in patients with metastatic colorectal cancer who have failed selected previous treatments.</brief_summary>
	<brief_title>Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Metastatic colorectal cancer Failed selected cancer therapies in the past. Prior treatment with tyrosine kinase inhibitors or VEGF inhibitors other than bevacizumab.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
</DOC>